1.A Clinical and Histopathological Study of 76 Cases of Neurofibroma.
Seok Rim KIM ; Yun Sun MOON ; Chi Yeon KIM
Korean Journal of Dermatology 2015;53(6):492-493
No abstract available.
Neurofibroma*
2.Effects of Reactive Oxygen Metabolite on the Calcium Transport of Cardiac Mitochondria.
Myung Suk KIM ; Yun Song LEE ; Seok Chan HONG
Korean Circulation Journal 1994;24(1):145-155
BACKGROUND: Intracellular calcium overload is a common final feature of the ischemic-reperfused heart and mediates the genesis of irreversible cell damage. Reactive oxygen medabolites have been known to play and important role as toxic mediators in myocardial injuries resulting from ischemia and reperfusion. In order to investigate the mechanism of intracellular calcium accumulation in the ischemic-reperfused myocardium, the present study observed the possible contribution of the reactive oxygen metabolite to the calcium transport of cardiac mitochondria. METHODS: Mitochondrial were isolated from rabbit hearts. The effects of a reactive oxygen metabolite, H2O2 on calcium uptake and release, redox states of endogenous pyridine nucleotides and glutathiones of mitochondria respiring with succinate were observed. Calcium uptake and release were monitored by dual-wave length spectrophotometer using a calcium indicator, arsenaze III. Contents and redox states of pyridine nucleotides and glutathiones were measured by enzymatic methods using spectrofluorometer and HPLC. RESULTS: Hydrogen peroxide(10-500microM) promoted calcium release dose-dependently from CA++-preloaded mitochondria, but did not affect the mitochondrial calcium uptake. The H2O2-induced calcium release was accompanied by simultaneous oxidation of the pyridine nucleotides and decrease in the content of the reduced form of glutathione(GSH). When mitochondria were treated with BCNU(N,N=bis(2-chloroethyl)-N-nitrosourea) to inhibit glutathione reductase and so as to reduce the GSH content, there were no increase in calcium release from the mitochondria. These results may indicate that H2O2 increases the permeability of cardiac mitochondrial membrane to calcium in association with the changes in redox state of endogenous pyridine nucleotides, but not with that of glutathiones. CONCLUSION: It is suggested that the reactive oxygen metabolites induce the release of calcium from mitochondria by altering the redox state of pyridine nucleotides, and it may partly be involved in the elevation of cytosolic calcium concentration in the ischemic-reperfused myocardial cells.
Calcium*
;
Chromatography, High Pressure Liquid
;
Cytosol
;
Glutathione Reductase
;
Heart
;
Hydrogen
;
Ischemia
;
Mitochondria*
;
Mitochondrial Membranes
;
Myocardium
;
Nucleotides
;
Oxidation-Reduction
;
Oxygen*
;
Permeability
;
Reperfusion
;
Succinic Acid
3.Three cases of tinea capitis caused by Microsporum Ferrugineum.
Han Uk KIM ; Cahang Jun CHOI ; Seok Kweon YUN
Korean Journal of Dermatology 1993;31(5):760-764
Microsporum ferrugineum was the most common cause of tinea captis in Korea until the middle of the 1970s, but this organism has been only rarely isolated from the scalp ringworm during recent years. We report, three cases of tinea capitis occurring in a 2-year-old male, a 10 year-old female and a 5-year-old male. From all three patients, Microsporum ferrugineum was isolated.
Child
;
Child, Preschool
;
Epidemiology
;
Female
;
Humans
;
Korea
;
Male
;
Microsporum*
;
Scalp
;
Tinea Capitis*
;
Tinea*
4.Plasma Levels of Dehydroepiandrosterone Sulfate ( DHEA - S ) and Total Testosterone in the Patients with Female androgenetic Alopecia.
Seok Kweon YUN ; Hong Yong KIM ; Chull Wan IHM
Korean Journal of Dermatology 1995;33(6):1060-1065
BACKGROUND: It has been known that androgenetic alopecia in both male and female is due to the role of the androgen hormone in the hair follicle, but the level of the androgen hormone in the plasma is controversial in relation with the development of the alopecia. OBJECTIVE: We have tried the clarify if there is any or no difference in the plasma levels of the hormones between the normal female and the patient with alopecia, because the range of the plasma DHEA-S and total testosterone in the normal female is very wide. METHODS: Plasma levels if the hormones were examined in 22 patients with female androgenetic alopecia and 20 normal females. RESULTS: 1. In DHEA-S, 21(95.5%) aut of 22 female androgenetic alopecia patients were in the normal range while 20(100%) of the 20 normal females were all within the normal range. However the mean value of the hormone(88.89+101.41 g/dl) in the patient group was significantly higher than that(82.18+44.03 g/dl) of the normal group(p<0.05). 2. In total testosterone, 17(94.4%) out of the 18 patents were in the normal range while 20 (100%) of 20 normal females were all within the normal range. However the mean value of the hormone(0.22+0.20ng/ml) in the patient group was significantly higher than that(0.08+0.09ng/ml) of the normal group(p<0.05). 3. As for distribution of DIEA S according to the age, the value of the patient group was higher than that of the normal group in all age groups studied. In the distribution of total testosterone according to age, there was no difference between the normal and the patient in the twenties. After the twenties, the testosterone levels were higher in the patients than the normal females. CONCLUSION: There were significant differences in mean values of plasma DHEA-S and total testosterone between the patients and the normal females although individuals in both groups were largely wit,hin normal range of the hormones.
Alopecia*
;
Dehydroepiandrosterone Sulfate*
;
Dehydroepiandrosterone*
;
Female*
;
Hair Follicle
;
Humans
;
Male
;
Plasma*
;
Reference Values
;
Testosterone*
5.Hepatocellular Carcinoma with Severe Hypoglycemia: Involvement of Insulin-ike Growth Factor I, II and Insulin-ike Growth Factor Binding Proteins.
Seok Joo KIM ; Bo Yeong YUN ; Ha Chin CHOI
The Korean Journal of Hepatology 1999;5(4):332-337
We report a case of hepatocellular carcinoma presented with severe hypoglycemia. Computerized tomography and ultrasonography revealed a massive bilateral tumor with portal vein thrombosis. The levels of IGF-I (113 ng/mL) and IGFBP- (815 ng/mL) measured in the plasma, were lower than normal range. There was strong immunoreactivity of IGF- and IGF-I in immunohistochemical stain of tumor cells.
Carcinoma, Hepatocellular*
;
Carrier Proteins*
;
Fibrinogen*
;
Hypoglycemia*
;
Insulin-Like Growth Factor Binding Proteins
;
Insulin-Like Growth Factor I
;
Plasma
;
Reference Values
;
Ultrasonography
;
Venous Thrombosis
6.Surgical treatment of hypothalamic hamartoma
Young Seok Park ; Yun Ho Lee ; Kyu-Won Shim ; Dong-Seok Kim
Neurology Asia 2010;15(Supplement 1):15-20
Hypothalamic hamartomas are often associated with early onset gelastic seizures, precocious puberty,
behavioral problem and suboptimal response to antiepiletptic drugs. Until now, four surgical options
have been reported to reduce seizure by >50%. Surgical excision have good seizure outcome but
postoperative complications were not infrequent, whether by pterional or transcallosal interforniceal
approach. Radiosurgery is noninvasive alternative to resective surgery but the effect usually does not
appear until several months later. Radiofrequency ablation is less invasive than surgical resection and
its effect is immediate, but lacks long term follow-up data. It also requires three dimensional analysis of
the lesion to enhance effi cacy and safety. As hypothalamic hamartoma is intrinsically epileptogenic and
epileptogenic discharges spread from the lesion, blocking the seizure propagation through endoscopic
disconnection is regarded as an effective and safer option. Surgical choice for a particular patient
should take into account the hamartoma’s size, location, surgeon’s preferences, possible complication
as well as the effect and risk of the various surgical methods. In the present review, open surgery,
endoscopic disconnection, radiosurgery and radiofrequency ablation are discussed.
7.A Case of Necrobiosis Lipoidica Treated with Cyclosporine.
Do Hun KIM ; Sang Yun JIN ; Yun Seok CHOI ; Ai Young LEE ; Seung Ho LEE
Korean Journal of Dermatology 2013;51(6):484-485
No abstract available.
Cyclosporine
;
Necrobiosis Lipoidica
;
Necrobiotic Disorders
8.Correction of Dark Coloration of the Lower Eyelid Skin with Nanofat Grafting.
Dong Seok OH ; Dae Hwa KIM ; Tai Suk ROH ; In Sik YUN ; Young Seok KIM
Archives of Aesthetic Plastic Surgery 2014;20(2):92-96
BACKGROUND: A number of factors can cause dark circles around the eyes including excessive pigmentation, thin and translucent lower eyelid skin overlying the orbicularis oculi muscle, and shadowing due to skin laxity and tear trough. Autologous fat graft is an effective method for the treatment of lower lid dark circles, but irregularities caused by leaving visible lumps of the fat can occur. Tonnard et al. suggested 'nanofat' grafting and introduced its characteristics and clinical applications. The authors used their nanofat grafting to correct lower eyelid dark circles. METHODS: Nanofat grafting was performed in 19 patients for dark lower eyelids. The grafts were injected into subdermal layer using blunt cannula. Microfat grafting with nasojugal fold was performed to all the patients. Among them, 18 patients received transconjunctival fat removal at the same time. RESULTS: All the patients showed much improvement from preoperative dark coloration. There were no visible lumps of fat, contour irregularities, or fat necrosis. Postoperative edema and ecchymosis were minimal. CONCLUSIONS: Nanofat grafting methods provide a good alternative for correcting dark circles by augmenting thin skin with lower complications. This simple, cost effective procedure is suitable for correction of dark circles and various skin rejuvenation purposes.
Catheters
;
Ecchymosis
;
Edema
;
Eyelids*
;
Fat Necrosis
;
Humans
;
Hyperpigmentation
;
Pigmentation
;
Rejuvenation
;
Shadowing (Histology)
;
Skin*
;
Transplantation
;
Transplants*
9.Cardiac Valve Replacement in Children.
Youn Woo KIM ; I Seok KANG ; Ho Sung KIM ; Chung Il NOH ; Jung Yun CHOI ; Yong Soo YUN
Korean Circulation Journal 1992;22(3):479-487
BACKGROUND: Valve replacement in children has many problems such as the durability of prosthetic valve, thomboembolism and hemorrhage. But recently, the necessity of valve replacement in children increased and the above problems were solved party. So the number of valve replacement in children increased progressively. RESULTS: Valve replacement in 47 children were done at Seooul National University Chidren's Hospital from March 1986 to July 1991. The patients were composed of 25 males and 33 females. 25 patients had congenital heart disease and 22 patients rheumatic heart disease. 45 patients received single valve repalcement, 2 patients double valve repalcement, and among all of them, 2 patients redo-replacement. The major valve lesion was mitral insufficiency and post-operative status in view of NYHA functinonal class was improved in most patients. The mechanical valves were applied to 45 patients and tissue valves to 2 patients. The indication of valve replacement were progressive increase in ventricular volume, major regurgitant fraction over grade III decrease in exercise tolerance and vegetation. The overall early mortality was 8.5% and late mortality 0%. There were post-operative complication rate of 30% and late complication rate 14%, and among the later, valve faliure was reported in 2 pantients and thromboembolism in 1 patient. The complication-free rate was 97.7% at post-operative 1 month, 91.3% at 12 months, 90% at 36 months and 60% at 48 months. 43 patients received anticoagulation and/or antiplatelet therapy, but there was no critical indication for this. CONCLUSION: These results suggest that cardiac valve replacement in children have been effective therapeutic modality even though various problems still remain, but we propose that sufficient long-term follow-up and clinical research be needed.
Child*
;
Exercise Tolerance
;
Female
;
Follow-Up Studies
;
Heart Defects, Congenital
;
Heart Valves*
;
Hemorrhage
;
Humans
;
Male
;
Mitral Valve Insufficiency
;
Mortality
;
Rheumatic Heart Disease
;
Thromboembolism
10.Combined Treatment with Metallic Stent Placement and Radiotherapy in Malignant Biliary Obstruction.
Chul Yong KIM ; Yun Hwan KIM ; Taek Soo RHO ; Chang Hee LEE ; Hoe Seok JUNG
Journal of the Korean Radiological Society 1994;31(6):1045-1049
PURPOSE: To evaluate the efficacy of combined treatment of metallic biliary stent placement and radiotherapy in malignant biliary obstruction. MATERIALS AND METHODS: Between January 1992 and February 1994, 22 patients with malignant biliary obstruction were treated with metallic biliary stent placement and radiotherapy. The causes of the obstruction included cholangiocarcinoma(n=14), gallbladder carcinoma(n=4), colon cancer(n=2), pancreatic head cancer (n=1), and stomach cancer(n=1). According to the sites of obstruction level, patient were divided into 2 groups; hilar obstruction(n=18) and common bile duct obstruction(n=4). The patients received dose of 45 Gray/18 fraction by external radiotherapy and 20Gy/8f by high dose rate brachytherapy with iridium--192 source through percutaneous transhepatic biliary drainage(PTBD) catheter. The duration of stent patency after placement, survival period and survival rate by Kaplan Meier method were calculated in dead and alive patients, respectively. RESULTS: In all 22 patients, the duration of stent patency was 5.5(1.3--18.5)months. Survival periods after stent placement and PTBD were 5.3(2.0--8.5 )months and 7.9(4.0--14.7)months respectively in 9 dead patients and 7.7(1.3--21.0)months and 9.5(2.3--23.0)months in 13 alive patients. In all 22 patients, the survival rates in 6, 12 and 18 months were 78.9%, 47.5 % and 35.6 %, respectively. CONCLUSIONS: The results with combined metallic biliary stent placement and radiotherapy for the palliative treatment of malignant biliary obstruction in this study was more favorable, as compared with those of the other authors with only metallic biliary stent placement.
Brachytherapy
;
Catheters
;
Colon
;
Common Bile Duct
;
Gallbladder
;
Head and Neck Neoplasms
;
Humans
;
Palliative Care
;
Radiotherapy*
;
Stents*
;
Stomach
;
Survival Rate